Suppr超能文献

天麻钩藤饮治疗肝阳上亢型自发性高血压大鼠的药效学和代谢组学研究。

Pharmacodynamics and metabonomics study of Tianma Gouteng Decoction for treatment of spontaneously hypertensive rats with liver-yang hyperactivity syndrome.

机构信息

Tianjin Medical University, Tianjin, 300070, China; Department of Cardiology, Tianjin Chest Hospital, Tianjin, 300051, China; Basic Medical College, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.

Department of Cardiology, Second Affiliated Hospital of Tianjin University of TCM, Tianjin, 300131, China.

出版信息

J Ethnopharmacol. 2020 May 10;253:112661. doi: 10.1016/j.jep.2020.112661. Epub 2020 Feb 11.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Essential hypertension is a prevalence chronic cardiovascular disease, which is treated by traditional Chinese medicine (TCM) in China. Metabolomics approach has achieved more attention in pharmacology studies of natural products. Tianma Gouteng Decoction (TGD) is effective for the therapeutic of hypertension in China. We aimed to investigate antihypertension effect of TGD on spontaneous hypertension rat (SHR) with live-Yang hyperactivity hypertension (Gan Yang Shang Kang, GYSK) and explore the mechanism by metabolomics method.

MATERIALS AND METHODS

After establishing the GYSK-SHR model by giving aconite decoction, rats were randomly divided into four groups including model group, TGD qd group (66.88 mg/kg, once a day), TGD bid group (33.44 mg/kg, twice a day), TGD tid group (22.29 mg/kg, three times a day). Blood pressure (BP) and indexes of renin-angiotensin-aldosterone system (RAAS system) were measured. Metabolic profiling of rat plasma samples was performed by UPLC-Q-TOF/MS, which was analyzed with principal component analysis (PCA) and partial least-squares-discriminate analysis (PLS-DA) to explore the relationship between metabolic pathways and hypertension.

RESULTS

To better explain the role of TGD on hypertension, we detected three different frequencies of TGD treatment with equal dosage. TGD reduced the BP in GYSH-SHR model and regulated the serum levels of NE, Ang II, ET, 5-HT, CRP, RENIN and ALD especially at TGD bid group. By UPLC-Q-TOF/MS analysis, we found 47 potential biomarkers in GYSK-SHR rats from the plasma metabolites, among which 15 biomarkers were regulated by TGD. Consisted with the antihypertension activity, TGD bid group showed the significantly moderating effect on the regulating biomarkers.

CONCLUSIONS

TGD exhibited the antihypertensive activity at the frequency of administration twice a day, which had the association with RAAS system and mediated 15 biomarkers by regulating metabolisms of glycerol phospholipid, sphingomyelin, energy and amino acid.

摘要

民族药理学相关性

原发性高血压是一种常见的慢性心血管疾病,在中国,它可以通过中药(TCM)进行治疗。代谢组学方法在天然产物的药理学研究中得到了越来越多的关注。天麻钩藤汤(TGD)对中国高血压的治疗有效。我们旨在通过代谢组学方法研究 TGD 对自发性高血压大鼠(SHR)的降压作用,这些大鼠表现出“阳亢”高血压(Gan Yang Shang Kang,GYSK)的特征。

材料和方法

通过给予乌头汤建立 GYSK-SHR 模型后,将大鼠随机分为 4 组,包括模型组、TGD qd 组(66.88mg/kg,每天 1 次)、TGD bid 组(33.44mg/kg,每天 2 次)、TGD tid 组(22.29mg/kg,每天 3 次)。测量血压(BP)和肾素-血管紧张素-醛固酮系统(RAAS 系统)的指标。采用 UPLC-Q-TOF/MS 对大鼠血浆样品进行代谢组学分析,通过主成分分析(PCA)和偏最小二乘判别分析(PLS-DA)进行分析,以探讨代谢途径与高血压之间的关系。

结果

为了更好地解释 TGD 对高血压的作用,我们以相等的剂量检测了 TGD 三种不同的给药频率。TGD 降低了 GYSH-SHR 模型中的 BP,并调节了血清中 NE、Ang II、ET、5-HT、CRP、RENIN 和 ALD 的水平,尤其是在 TGD bid 组。通过 UPLC-Q-TOF/MS 分析,我们从血浆代谢物中发现了 47 种潜在的生物标志物,其中 15 种生物标志物被 TGD 调节。与降压活性一致,TGD bid 组对调节生物标志物的作用明显增强。

结论

TGD 以每天给药 2 次的频率表现出降压活性,这与 RAAS 系统有关,并通过调节甘油磷脂、神经鞘磷脂、能量和氨基酸代谢来调节 15 种生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验